Complex regional pain syndrome after infliximab infusion.
Chahine
Lama M
LM
Patrick
Robert
R
Tavee
Jinny
J
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D020918:Complex Regional Pain Syndromes / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D005260:Female; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab